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• Group quarters at the community level that include the
location, size, and type of nursing home facilities and
mental health facilities.
• Major roads, state, metropolitan area, and county
boundaries.
• Bus routes in select communities.
This model advances the state of disease transition modeling
science by developing a set of documented tools that
constitute an analog to a higher level language that supports
the rapid development of large ABMs for studying problems
analogous to disease transmission problems. This resource
uses the above data resources deﬁnes above and it permits
the properties of ABMs, the natural history of infectious
diseases and the characteristics of the social networks
that those diseases utilize transmit within to be studied
experimentally.
*MIDAS Models of Infectious Disease Agents Study.
PL-06 Examining the fourth stage of epidemiological
transition in China: Some implications for health
and health care provision
M.M. Islam*, L.J. Pei, X.M. Song, X.Y. Zheng. Institute of
Population Research, Peking University, Beijing-100871,
China
Today’s China is experiencing the new epidemiological
phase, characterized by increasing life expectancy and
disease of afﬂuence coupled with emerging and re-emerging
diseases. Under this situation it is important to think
strategically in the planning of health care provision of
all population which is particularly important for rapidly
modernizing present China. The aim of this paper is to
analyze the fourth stage of epidemiological transition in
current China based on existing theoretical framework by
using descriptive statistical methods of analysis and to
seek for some policy implications for health and health
care provisions. Mortality data suggests that China has well
entered to the fourth stage of epidemiological transition-the
age of delayed degenerative diseases where Cardiovascular,
cancer, respiratory and digestive diseases are the leading
causes of death while the life expectancy has reached to
more than 70 years. Study indicates that the increase in
non-communicable diseases signiﬁcantly increases the cost
of illness and the burden of health care system. Moreover
HIV/AIDS, and other emerging diseases like bird ﬂu, SARS
have become new threats to public health. Demographic
and life style changes are likely to result in a substantial
increase in non-communicable diseases in next coming years
where it is an urgent priority to execute the policies to
prevent the growing epidemics. Thus this paper examines
the predominant major degenerative causes of death and
the risk of dying from these diseases redistributing to older
ages of people in China and to point out the new targets of
health care policies under changing dilemmas.
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Background: HIV co-infection increases HCV-related hepatic
ﬁbrosis progression, HCV persistence, and decreases
response rates to interferon-based anti-HCV therapy. We
have demonstrated that HIV increases HCV replication
through enhancement of TGF-b1 expression. We sought to
further explore the mechanism by which TGF-b1 regulates
HCV through TGF-b1 signal pathways.
Methods: Huh7.5.1 cells were incubated with active or heat
inactivated JFH1. Human TGF-b1 was tested for its effect on
JFH1 uptake and replication. HCV levels in cell lysates were
analyzed by HCV core ELISA and Q-PCR. TGF-b1 signaling
was measured using a highly TGF-b1 responsive PAI1-Luc
reporter construct. The effects of the ERK1/2 inhibitor
U0126 and the PI3K inhibitor Ly294002 on JFH1 replication
were analyzed.
Results: TGF-b1 increased active uptake of both active and
inactivated JFH1 by over 3 fold at 4 hrs, and increased
active JFH1 uptake and replication by over 5-fold at 24
hrs compared to untreated cells. U0126 decreased HCV
replication by 67% and blocked TGF-b1 mediated PAI1
promoter signaling by 2.2-fold in Huh7.5.1 cells and 3.6-
fold in JFH1-infected Huh7.5.1 cells. U0126 reduced TGF-
b1 stimulated phospho-ERK1/2 in both uninfected and
JFH1-infected Huh7.5.1 cells by Western blot. In contrast,
Ly294002 did not block TGF-b1 mediated PAI1 promoter
transcription or HCV replication enhancement.
Conclusions: Our data conﬁrm that HIV appears to promote
HCV replication through upregulating TGF-b1 in HCV-
infected hepatocytes. TGF-b1 has a permissive effect on
HCV uptake and replication. HCV replication enhancement
takes place through both indirect (increasing viral uptake)
and direct (regulation of HCV replication) means.
PL-08 Activation of VEGF-A/AKT/mTOR signal in
ground glass hepatocytes and transgenic livers
of Pre-S mutant: Implication for hepatitis B
virus-related hepatocarcinogenesis
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Tainan, Taiwan, 2Graduate Institutes of Basic Medicine
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Background and Aim: Ground glass hepatocytes (GGH)
harbor HBV pre-S mutants in endoplasmic reticulum (ER) and
represent the precursor lesions of hepatocellular carcinoma
(HCC). Whether growth factors play a role in the progression
from GGHs to HCC is investigated.
Methods: Growth factor(s) upregulated by pre-S mutants
was identiﬁed using a cytokine/growth factor array in
Huh-7 cells. Immunohistochemistry, RT-PCR, and Western
blot analysis were performed to study the participation of
these genes and their pathways in cells, liver tissues, and
transgenic livers.
Results: Vascular endothelial growth factor (VEGF)-A was
identiﬁed as the potential growth factor upregulated
by pre-S mutants. By immunohistochemistry, GGHs and
the transgenic mouse livers of pre-S2 mutant showed
enhanced expression of VEGF-A. The VEGF-A upregulation
by pre-S mutants could be suppressed by vomitoxin, an
ER stress inhibitor. Furthermore, pre-S mutants-expressed
Huh-7 cells exhibited activation of Akt/mTOR signaling
and increased growth advantage, which could be inhibited
by VEGF-A neutralization. Consistent with this notion,
enhanced expression of VEGF-A and activation of Akt/mTOR
signaling, comparable to the levels of paired HCC tissues,
were also detected in HBV-related non-tumorous livers.
Conclusion: The enhanced expression of VEGF-A in GGHs,
probably associated with pre-S mutants-induced ER stress,
may provide a potential mechanism for the progression from
GGHs to HCC through Akt/mTOR signaling in chronic HBV
infection.
